scPharmaceuticals
scPharmaceuticals is a Massachusetts-based pharmaceutical company that develops and markets parenteral antimicrobial therapies to treat heart failure and bacterial infections.
Business Model:
Revenue: $7.5M
Employees: 11-50
Industries / Tags:
Detailed scPharmaceuticals Information
Geographic Data
Address: 2400 District Avenue
City: Burlington
State: MA
Zip: 01803
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$100M
Raised Total:$232M
Social
Metrics
7,286,462Website Global Rank
803Website Monthly Traffic
Twitter Followers
Description
scPharmaceuticals is a Massachusetts-based pharmaceutical company that develops and markets parenteral antimicrobial therapies to treat heart failure and bacterial infections.
Contact Phone:
+16175170730
Contact Email:
scPharmaceuticals went public on 11/17/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/17/2017
IPO Valuation:
$246M
Ticker Symbol:
SCPH
IPO Price:
$14/share
Amount Raised:
$90M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2017 | IPO | $90M | 11/2022 | Post-IPO Equity | $50M | 3/2014 | Series A | 2 | $16M |
5AM Ventures Lundbeckfonden Ventures 5AM Ventures Lundbeckfonden Ventures 5AM Ventures Lundbeckfonden Ventures 5AM Ventures Lundbeckfonden Ventures |
12/2016 | Series B | $47M |
OrbiMed 5AM Ventures Lundbeckfond Ventures |
5/2020 | Post-IPO Equity | $50M | 9/2019 | Post-IPO Debt | 2 | $20M |
Solar capital Silicon Valley Bank Silicon Valley Bank Solar capital Solar capital Silicon Valley Bank Silicon Valley Bank Solar capital |
1/2017 | Series B | 4 | $45.6M |
Sun Pharma Lundbeckfonden Ventures OrbiMed 5AM Ventures OrbiMed Sun Pharma Lundbeckfonden Ventures OrbiMed 5AM Ventures OrbiMed Sun Pharma |
10/2022 | Post-IPO Debt | 1 | $100M |
Oaktree Capital Management Oaktree Capital Management |
11/2022 | Post-IPO Equity | $50M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
